Affinium is a pharmaceutical company focused on the clinical development of antibacterials. Our lead development program encompasses a potent, orally available, novel antibiotic class for the treatment of antibiotic resistant staphylococcal infections.

For information, please contact:

Owen Roberts, CFA, Chief Financial Officer
Affinium Pharmaceuticals, Inc.

US Office:
7000 North Mopac Expwy.
2nd Floor
Austin, Texas, 78731
Phone: 512-514-6630
Fax: 512-514-6632

Canadian Office:
1243 Islington Ave.
Suite 600
Toronto, Ontario, M8X 1Y9
Phone: 416-645-6600
Fax: 416-646-1553

corporate@afnm.com